faCellitate
Mannheim
About faCellitate
faCellitate develops polymeric platforms that aim at supporting cancer and stem cell research, drug discovery, toxicology, and tissue engineering. The platform facilitates cellular interaction, significantly improving cell culture in biological research.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $3.7M
- Funding stage: Seed
- Last round: Seed (Sep 2022)
- Website: facellitate.com
- Phone: [email protected]
Industries & Categories
Biotechnology
Social Profiles
Canonical: https://fsome.com/organization/facellitate-37489 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.